Combined use of MLPA and nonfluorescent multiplex PCR analysis by high performance liquid chromatography for the detection of genomic rearrangements

被引:15
作者
De Lellis, Laura
Curia, Maria Cristina
Catalano, Teresa
De Toffol, Simona
Bassi, Chiara
Mareni, Cristina
Bertario, Lucio
Battista, Pasquale
Mariani-Costantini, Renato
Radice, Paolo
Cama, Alessandro
机构
[1] Univ G DAnnunzio, Dept Oncol & Neurosci, Chieti, Italy
[2] Univ G dAnnunzio, Ctr Excellence Aging, Chieti, Italy
[3] Univ Messina, Dept Expt Pathol & Microbiol, Messina, Italy
[4] FIRC Inst Mol Oncol Fdn, Milan, Italy
[5] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy
[6] Ist Nazl Tumori, Dept Expt Oncol & Labs, Milan, Italy
[7] Ist Nazl Tumori, Hereditary Colorectal Tumor Registry, Milan, Italy
关键词
semiquantitative analysis; molecular diagnosis; gene dosage; HNPCC; MLH1; MSH2;
D O I
10.1002/humu.20386
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Large genomic rearrangements are recognized as playing a pathogenic role in an increasing number of human genetic diseases. It is important to develop efficient methods for the routine detection and confirmation of these germline defects. Multiplex ligation-dependent probe amplification (MLPA) is considered an early step for molecular diagnosis of several genetic disorders. However, artifacts might hamper the interpretation of MLPA analysis, especially when rearrangements involve a single exon. Therefore, rearrangements must be verified by two independent methods. In this study, we developed nonfluorescent multiplex-PCR coupled to high, performance liquid chromatography (NFMP-HPLC) and analyzed whether the use of this method combined with MLPA could be helpful in the detection and confirmation of gross MSH2 and MLH1 genomic rearrangements. A total of nine nonfluorescent multiplex-PCRs were developed to analyze the 16 MSH2 and 19 MLH1 exons. Reliable multiplex amplifications and nonfluorescent peak quantitation were obtained with a limited number of cycles (<= 25) using a denaturing HPLC (DHPLC) instrument under nondenaturing conditions. The results obtained by NFMP-HPLC were highly reproducible. The combined use of MLPA and NFMP-HPLC identified and independently confirmed putative MLH1 and MSH2 deletions in eight out of 50 unrelated patients with hereditary nonpolyposis colorectal cancer (HNPCC). In five cases, the deletions affected a single exon and in three cases multiple contiguous exons. These results were in agreement with breakpoint and complementary DNA (cDNA) analyses. Considering that MLPA and NFMP-HPLC are unlikely to be affected by the same artifacts, their combined use could also provide a robust and cost-effective strategy for routine screening and confirmation of putative rearrangements in other genes, especially when a single exon is involved or a precise characterization of breakpoints is not achieved.
引用
收藏
页码:1047 / 1056
页数:10
相关论文
共 31 条
[11]   Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC [J].
Di Fiore, F ;
Charbonnier, F ;
Martin, C ;
Frerot, S ;
Olschwang, S ;
Wang, Q ;
Boisson, C ;
Buisine, MP ;
Nilbert, M ;
Lindblom, A ;
Frebourg, T .
JOURNAL OF MEDICAL GENETICS, 2004, 41 (01) :18-20
[12]   Structural variation in the human genome [J].
Feuk, L ;
Carson, AR ;
Scherer, SW .
NATURE REVIEWS GENETICS, 2006, 7 (02) :85-97
[13]   Determination of SNP allele frequencies in pooled DNAs by primer extension genotyping and denaturing high-performance liquid chromatography [J].
Giordano, M ;
Mellai, M ;
Hoogendoorn, B ;
Momigliano-Richiardi, P .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 2001, 47 (1-2) :101-110
[14]   Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF [J].
Houdayer, C ;
Gauthier-villars, M ;
Laugé, A ;
Pagès-Berhouet, S ;
Dehainault, C ;
Caux-Moncoutier, V ;
Karczynski, P ;
Tosi, M ;
Doz, F ;
Desjardins, L ;
Couturier, J ;
Stoppa-Lyonnet, D .
HUMAN MUTATION, 2004, 23 (02) :193-202
[15]   ANALYSIS OF DELETIONS IN DNA FROM PATIENTS WITH BECKER AND DUCHENNE MUSCULAR-DYSTROPHY [J].
KUNKEL, LM ;
HEJTMANCIK, JF ;
CASKEY, CT ;
SPEER, A ;
MONACO, AP ;
MIDDLESWORTH, W ;
COLLETTI, CA ;
BERTELSON, C ;
MULLER, U ;
BRESAN, M ;
SHAPIRO, F ;
TANTRAVAHI, U ;
SPEER, J ;
LATT, SA ;
BARTLETT, R ;
PERICAK-VANCE, MA ;
ROSES, AD ;
THOMPSON, WV ;
RAY, PN ;
WORTON, RG ;
FISCHBECK, KH ;
GALLANO, P ;
COULON, M ;
DUROS, C ;
BOUE, J ;
JUNIEN, C ;
CHELLY, J ;
HAMARD, G ;
JEANPIERRE, M ;
LAMBERT, M ;
KAPLAN, JC ;
EMERY, A ;
DORKINS, H ;
McGLADE, S ;
DAVIES, KE ;
BOEHM, C ;
ARVEILER, B ;
LEMAIRE, C ;
MORGAN, GJ ;
DENTON, MJ ;
AMOS, J ;
BOBROW, M ;
BENHAM, F ;
BOSWINKEL, E ;
COLE, C ;
DUBOWITZ, V ;
HART, K ;
HODGSON, S ;
JOHNSON, L ;
WALKER, A .
NATURE, 1986, 322 (6074) :73-77
[16]   THE MOLECULAR-BASIS OF ALPHA THALASSEMIA IN A SOUTH-AFRICAN POPULATION [J].
MATHEW, CGP ;
ROUSSEAU, J ;
REES, JS ;
HARLEY, EH .
BRITISH JOURNAL OF HAEMATOLOGY, 1983, 55 (01) :103-111
[17]   Large deletions of the APC gene in 15% of mutation-negative patients with classical polyposlis (FAP): A Belgian study [J].
Michils, G ;
Tejpar, S ;
Thoelen, R ;
van Cutsem, E ;
Vermeesch, JR ;
Fryns, JP ;
Legius, E ;
Matthijs, G .
HUMAN MUTATION, 2005, 25 (02) :125-134
[18]   Genomic rearrangements account for more than one-third of the BRCA1 mutations in northern Italian breast/ovarian cancer families [J].
Montagna, M ;
Palma, MD ;
Menin, C ;
Agata, S ;
De Nicolo, A ;
Chieco-Bianchi, L ;
D'Andrea, E .
HUMAN MOLECULAR GENETICS, 2003, 12 (09) :1055-1061
[19]  
Nakagawa Hidewaki, 2003, Hum Mutat, V22, P258, DOI 10.1002/humu.9171
[20]   Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification [J].
Schouten, JP ;
McElgunn, CJ ;
Waaijer, R ;
Zwijnenburg, D ;
Diepvens, F ;
Pals, G .
NUCLEIC ACIDS RESEARCH, 2002, 30 (12) :e57